We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 20

Data protection in Canada: Court of Appeal confirms narrow approach

  • Torys LLP
  • -
  • Canada
  • -
  • January 30 2013

On January 18, 2013, the Federal Court of Appeal (FCA) released its decision in Takeda Canada Inc. v. The Minister of Health and Attorney General of

Sale of unlicensed natural health products in Canada to end

  • Torys LLP
  • -
  • Canada
  • -
  • January 28 2013

February 4, 2013 will mark the repeal of the Natural Health Products (Unprocessed Product Licence Applications) Regulations (NHP-UPLARs), which were

Canada’s PAAB releases updated Code of Advertising Acceptance

  • Torys LLP
  • -
  • Canada
  • -
  • December 7 2012

The Pharmaceutical Advertising Advisory Board (PAAB) has released a revised version of its Code of Advertising Acceptance

Health Canada announces intent to develop a framework for orphan drug approval

  • Torys LLP
  • -
  • Canada, USA
  • -
  • October 5 2012

On October 3, 2012, Health Canada issued a press release announcing that it will develop a framework for the marketing approval of drugs to treat rare life-threatening, seriously debilitating or serious chronic rare diseases that are commonly referred to as "orphan drugs."

Canada to change the regulation of “food-like" natural health products

  • Torys LLP
  • -
  • Canada
  • -
  • April 24 2012

On April 17, 2012, Health Canada announced that it will classify and transition all "food-like" natural health products (NHPs) to the regulatory framework that governs the sale of food products in Canada

Health Canada’s guidance document on PM(NOC) Regulations now finalized

  • Torys LLP
  • -
  • Canada
  • -
  • April 4 2012

Health Canada has published an update to its guidance document on the application of the Patented Medicines (Notice of Compliance) Regulations

Proposed amendment would exempt some generic submissions from Canada’s PM(NOC) regulations

  • Torys LLP
  • -
  • Canada
  • -
  • October 4 2011

Health Canada has released a proposed amendment to its guidance document Patented Medicines (Notice of Compliance) Regulations

Ontario companies doing business with hospitals may become subject to access-to-information requests

  • Torys LLP
  • -
  • Canada
  • -
  • April 6 2011

Pharmaceutical and medical device companies doing business with Ontario organizations that accept public funding, including hospitals, may be affected by recent legislative amendments aimed at increasing transparency and accountability of these entities

Canadian Consumer Product Safety Act aims to strengthen product safety laws

  • Torys LLP
  • -
  • Canada
  • -
  • April 4 2011

The Canadian Consumer Product Safety Act (CCPSA) will come into force on June 20, 2011

Canada amends regulations on adverse drug reaction reporting

  • Torys LLP
  • -
  • Canada
  • -
  • March 11 2011

Amended regulations regarding the reporting of adverse drug reactions came into force on February 10, 2011